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ABSTRACT Molecular and cellular analysis of early mammalian development is compromised by
the experimental inaccessibility of the embryo. Pluripotent embryonic stem (ES) cells are derived
from and retain many properties of the pluripotent founder population of the embryo, the inner cell
mass. Experimental manipulation of these cells and their environment in vitro provides an
opportunity for the development of differentiation systems which can be used for analysis of the
molecular and cellular basis of embryogenesis. In this review we discuss strengths and weaknesses
of the available ES cell differentiation methodologies and their relationship to events in vivo.
Exploitation of these systems is providing novel insight into embryonic processes as diverse as cell
lineage establishment, cell progression during differentiation, patterning, morphogenesis and the
molecular basis for cell properties in the early mammalian embryo.
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Pluripotent Cells and Early Mouse Development
One of the distinguishing features of early mammalian develop-
ment is the maintenance of a population of developmentally plastic,
pluripotent stem cells which give rise to all cells that constitute the
mature organism. Around 10-20 cells, which appear to be devel-
opmentally equivalent, make up the inner cell mass (ICM), located
at one end of the 3.5 d.p.c. (days post coitum) blastocyst. Mamma-
lian development entails the regulated proliferation of these cells
and allocation of descendants to specific cell lineages following
differentiation.
Around 4.0 d.p.c., ICM cells lining the blastocoelic cavity
differentiate to extraembryonic primitive endoderm. Pluripotence
is retained by internal ICM cells, referred to as the ‘epiblast’, now
surrounded by extraembryonic endoderm and trophectoderm. At
about the time the embryo implants into the uterine wall these
pluripotent cells begin to proliferate rapidly such that the 20-25
cells present at 4.5 d.p.c. expand to give rise to about 660 cells by
6.5 d.p.c. and 8060 cells by 7.5 d.p.c. (Snow, 1977). Concurrent
with pluripotent cell proliferation, primitive endoderm cells migrate
along the pluripotent cell surface and differentiate into one of two
cell types. Primitive endoderm cells that remain in contact with the
pluripotent cells differentiate into visceral endoderm while those
primitive endoderm cells that migrate onto the blastocoelic surface
of trophectoderm differentiate into parietal endoderm (Hogan et
al., 1994).
Formation of the proamniotic cavity within the pluripotent cell
population is first visible at 5.0 d.p.c. and is accompanied by
reorganisation of the cells into a pseudostratified columnar epithe-
lial sheet. Concomitant with this process, the pluripotent cells
become polarised, and undergo changes in gene expression
(Pelton et al., 2002) and developmental potential (Beddington,
1983a; Lake et al., 2000) suggesting that this morphologically
distinct pluripotent cell population, termed primitive ectoderm, is
derived from the ICM by differentiation. Primitive ectoderm pro-
vides the substrate for gastrulation, which is initiated at around 6.5
d.p.c.. This process transforms the pluripotent monolayer into a
multi-layered embryo consisting of the 3 primary germ layers,
mesoderm, endoderm and ectoderm.
While coordinated regulation of pluripotent cell proliferation,
differentiation and morphogenesis underpins development of the
mammal, relatively little is known of the signalling mechanisms that
regulate these processes at a cellular or molecular level. Accumu-
lating evidence implicates visceral endoderm as a source of
signals controlling primitive ectoderm formation, maintenance and
differentiation. Firstly, deletion of Evx1 and Hnf4, transcription
factors expressed in the visceral endoderm of the pre-gastrulation
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embryo, results in deterioration of the pluripotent cells around 5.0
d.p.c. (Spyropoulos and Cappechi, 1994) and increased apoptosis
of the primitive ectoderm by 6.5 d.p.c. (Duncan et al., 1994)
respectively. These observations identify visceral endoderm as a
source of signals that mediate formation and maintenance of the
primitive ectoderm. Recombination of Hnf4-/- embryos with Hnf4+/+
visceral endoderm rescues this defect resulting in formation of a
normal embryo capable of gastrulation (Duncan et al., 1997), thereby
confirming that the cellular defect in Hnf4-/- embryos is associated
with extraembryonic cell lineages. Expression of the paired-like
homeobox gene, Hesx1, in the anterior visceral endoderm at day
6-6.5 d.p.c. is followed by expression in the adjacent primitive
ectoderm within 24 hours (Thomas and Beddington, 1996). This
apparent patterning of the anterior primitive ectoderm is induced
from Hesx1 expressing visceral endoderm and is required for
appropriate specification since Hesx1-/- embryos show forebrain
deficiencies (Martinez-Barbera et al., 2000).
While the role of visceral endoderm as a source of inductive
signals for pluripotent cells is emerging from close analysis of gene
expression and knockout phenotypes, the molecular identity of
these signals has proven elusive, probably due to experimental
limitations associated with the early mouse embryo.
Embryonic Stem (ES) Cells: Their Origin, Properties and
Uses
Pluripotent embryonic stem (ES) cells are derived from out-
growths of the pluripotent cells of the pre-implantation mouse
embryo (Evans and Kaufman, 1981; Martin, 1981) and can be
maintained as a homogeneous population of undifferentiated cells
indefinitely in culture. ES cells share many properties with the
pluripotent cells of the ICM, including expression of the pluripotent
cell marker, Oct4, and expression of the more restricted markers
Rex1, which is expressed by the ICM but not later embryonic
pluripotent cell populations, and uvomorulin, which is not ex-
pressed by pluripotent cells of the primordial germ cell lineage
(Rathjen et al., 1999). Further, ES cells retain the pluripotent
developmental potential of the ICM, as demonstrated in vivo by
contribution to all tissues of the embryo and adult after reintroduc-
tion to mouse blastocysts (Bradley et al., 1984), and in vitro by the
formation of embryoid bodies (EBs), in which a broad range of
differentiated cell types representative of the three germ layers of
the mouse embryo are formed (Doetschman et al., 1985; Lake et
al., 2000). ES cells differ from their founding population in their
cytokine requirements. Maintenance of pluripotence in mouse ES
cells is reliant on activation of the gp130 receptor subunit, normally
achieved by addition of members of the IL-6 family of cytokines to
the culture medium (reviewed in Rathjen and Rathjen, 2001). As
yet, no role for gp130 signalling has been determined in the
establishment or maintenance of the pluripotent cell population in
vivo (Yoshida et al., 1996), although a role for gp130 activation in
embryonic diapause has been described (Nichols et al., 2001).
As a highly proliferative cell population that maintains, in culture,
the properties of a normal pluripotent cell, ES cells provide a unique
experimental resource for the analysis of mammalian develop-
ment. In this review we discuss exploitation of the ES cell system
to investigate cellular properties associated with pluripotent cells,
and to model cellular events that occur in vivo, such as differentia-
tion and cell fate specification.
Modelling Embryonic Differentiation: Formation of Primi-
tive Ectoderm from ES Cells
Modelling the first embryonic differentiation event, formation of a
population of pluripotent cells analogous to primitive ectoderm, can
be achieved through differentiation of ES cells as embryoid bodies
(EB) (Shen and Leder, 1992) or by co-culture of ES cells with MEDII,
a medium conditioned by the human hepatocellularcarcinoma cell
line, Hep G2 (Rathjen et al., 1999). Within EB, primitive ectoderm
exists transiently as a differentiation intermediate which arises during
the spontaneous differentiation of ES cells, and coexists with a
number of other cellular lineages, including derivatives of the ex-
traembryonic endodermal lineage and populations representative of
the embryonic germ lineages. The resulting differentiation environ-
ment is complex and deregulated, precluding maintenance, analysis
or controlled differentiation of the primitive ectoderm.
Fig. 1. Formation of EPL cells from ES cells. (A) ES cells form EPL cells
when cultured in MEDII, either in adherent culture for 2 days or suspension
culture for 4 days. EPL cells formed in suspension culture were identified
by in situ hybridisation with digoxygenin labelled anti-sense probes di-
rected against Fgf5. (B) Comparison of gene expression in ES and EPL cells
in culture and ICM and primitive ectoderm of the embryo (Chapman et al.,
1997; Rathjen et al., 1999; Pelton et al., 2002).
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lowing spontaneous differentiation and the generation of effec-
tively homogeneous populations of differentiated derivatives by
directed differentiation (Lake et al., 2000; Rathjen et al., 1999;
Rathjen et al., 2002). ES cells also differentiate to EPL cells when
cultured as cellular aggregates in suspension in medium supple-
mented with MEDII (Fig. 1A; Rathjen et al., 2002). The formation
of EPL cells occurs in the presence or absence of exogenous LIF,
but as would be predicted from in vitro and in vivo experiments
(Conquet et al., 1992; Shen and Leder, 1992), the acquisition of
primitive ectoderm characteristics is delayed in the presence of
gp130 signalling.
Formation and maintenance of EPL cells in culture is dependent
on the continued presence of MEDII, which can be separated into
two distinct biological activities, a high molecular weight compo-
nent of greater than 100 kDa and a low molecular weight activity of
less than 3 kDa (Rathjen et al., 1999). Analysis of the fractions
reveals that the low molecular weight activity is a small peptide
while the high molecular weight fraction has been identified as a
component of the ECM. In the absence of other signalling sources,
withdrawal of MEDII from EPL cells results in loss of pluripotence
and differentiation. However, when EPL cells are cultured in the
absence of MEDII in medium supplemented with LIF, pluripotence
is maintained and an ES cell morphology, gene expression and
developmental potential is established. The ability to revert to an
ES cell phenotype has been proposed to be a common feature of
pluripotent cells in culture (Matsui et al., 1992; Rossant, 1993).
Visceral endoderm and the liver share similarities with respect
to function and gene expression, despite their diverse embryologi-
cal origin (Rossant, 1995). Formation of primitive ectoderm from
ES cells in response to medium conditioned by a liver derived cell
line is therefore not unexpected, and suggests a functional similar-
ity between MEDII in vitro and visceral endoderm signalling in vivo.
Consistent with this, the small and large active components of
MEDII are expressed respectively by the visceral endoderm-like
cell line END-2, and within the basement membrane supporting the
pluripotent cells during primitive ectoderm formation (Bettess,
2001).
As a population of cells equivalent to embryonic primitive
ectoderm, EPL cells represent an important obligate intermediate
cell population in the differentiation of ES cells in culture. Establish-
ment of EPL cells in culture appears to follow closely the generation
of primitive ectoderm in vivo and represents an important first step
in the development of protocols for controlled, lineage specific
differentiation of pluripotent cells in culture. EPL cell formation and
differentiation therefore provides a system for the identification of
differentially expressed genes and transient intermediate cell
populations during pluripotent cell progression in vivo, and the
investigation of germ layer selection, differentiation, and patterning
of somatic lineages.
Distinct Subpopulations of Pluripotent Cells are Formed
during Developmental Progression of Pluripotent Cells
Although cellular criteria have been used to identify two pluripo-
tent cell populations within the early embryo (ICM and primitive
ectoderm), other evidence suggests that primitive ectoderm forma-
tion from ICM proceeds via temporally distinct intermediate pluri-
potent cell populations (Pelton et al., 1998). Utilising the ES to EPL
transition as an in vitro model for ICM to primitive ectoderm
formation, it has been possible to correlate differential gene ex-
pression in pluripotent cells in vitro and in vivo to provide a
molecular basis for the definition of transient pluripotent cell sub-
populations, and identify genes that may play important roles in
pluripotent cell developmental progression.
Differential display PCR on ES cells and EPL cells maintained
in culture for up to 8 days was used to identify novel differentially
Fig. 2. Summary of pluripotent cell gene expression in vivo and in vitro. The pluripotent cell
populations present within the early mouse embryo are aligned with approximate time points in
days post coitum (d.p.c.), the embryonic events characteristic of this developmental stage and
gene expression in pluripotent cell populations in vivo. ES cells and EPL cells grown for 2, 4 or
6 days in MEDII in the presence (+) or absence (-) of LIF are aligned on the basis of gene
expression in vitro. Fgf5 expression was not determined in 5.0 d.p.c. embryos.
Addition of MEDII to ES cells in adherent
culture results in the formation of a homoge-
neous population of pluripotent cells, termed
early primitive ectoderm-like (EPL) cells, which
exhibit many properties consistent with embry-
onic primitive ectoderm but distinct from ICM
and ES cells (Fig. 1A). EPL cell colonies form as
epithelial sheets, rather than the characteristic
domed colony structure of ES cells in culture,
and express Oct4 and the primitive ectoderm
marker Fgf5, but not the ICM marker Rex1. A
more detailed analysis of these markers, and
others isolated on the basis of differential ex-
pression in ES and EPL cells, indicated that
formation of EPL cells in vitro and primitive
ectoderm in vivo followed a similar progression
(Fig. 1B; Pelton et al., 2002). Rigorous demon-
stration of pluripotence is complicated by the
failure of both embryonic primitive ectoderm and
EPL cells to contribute to embryonic develop-
ment after introduction into host blastocysts
(Beddington, 1983a; Rathjen et al., 1999). How-
ever, consistent with the expression of pluripo-
tent cell markers, the extensive differentiation
potential of EPL cells has been demonstrated in
vitro by the formation of multiple cell types fol-
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regulated genes expressed in synchronous fashion throughout the
population. Expression of CRTR-1 appeared to be coordinately
regulated with expression of Rex1, a zinc finger protein regulated
by Oct4 expression (Ben-Shushan et al., 1998). Both genes are
expressed in ES cells and ICM, and downregulated in vitro in EPL
cells cultured for 2 days and in vivo between 4.5 d.p.c. and 4.75
d.p.c. This is a time associated with the onset of accelerated
pluripotent cell division in the embryo. Down regulation of CRTR-
1 and Rex1 coincided with up regulation of PRCE expression. Both
in vitro and in vivo PRCE expression was transient and down
regulated in EPL cells cultured past day 4, and after 5.25 d.p.c. of
embryonic development. Psc1 was expressed in ES cells and ICM
and down regulated in vitro in EPL cells cultured for 4 days and in
vivo between 5.0 and 5.25 d.p.c.. Fgf5, which is not expressed in
ES cells or ICM, is up-regulated to high levels in EPL cells cultured
for 4 days and throughout the embryonic primitive ectoderm,
although the exact timing of Fgf5 up-regulation has not been
established. Fgf5 expression is maintained in the pluripotent cells
before down-regulation associated with loss of pluripotence at
gastrulation.
All transcripts were expressed throughout the pluripotent cell
populations and no evidence was found for spatial heterogeneity
within this pool. Molecular homogeneity of pluripotent cells in the
pre-gastrulation embryo is consistent with the fate of heterotopic
transplanted primitive ectoderm from pre-streak or early primitive
streak embryos, which assumes a fate appropriate to the trans-
planted location (Beddington, 1983b; Parameswaran and Tam,
1995; Tam and Zhou, 1996). In the absence of spatial heterogene-
ity within the pluripotent population, patterning of the embryo must
therefore be established by signals originating from extraembry-
onic cell types, consistent with the results emerging from embry-
onic analysis (Beddington and Robertson, 1999).
While the availability of differentially expressed pluripotent cell
markers within embryonic populations refines knowledge of the
temporal progression of pluripotent subpopulations in vivo (Fig. 2),
it is not clear whether these represent distinct cell types which can
be maintained stably in appropriate conditions. An alternative
explanation is that they represent transient intermediates which
are developmental equivalents of transformed EC cells isolated
from teratocarcinomas. Changes in gene expression may reflect
alterations in the competence of the pluripotent cells to respond to
embryonic signalling, a possibility consistent with the temporal
correlation between changes in gene expression and cellular
events in vivo such as proliferation and cavitation. Analysis of the
promoters of differentially expressed genes may allow definition of
downstream signalling pathways operating in the embryo at these
times.
EPL Cell Differentiation In Vitro provides a Model for
Formation of the Primary Germ Layers of the Mamma-
lian Embryo
The aggregation of EPL cells, in a manner analogous to embry-
oid body formation by ES cells, results in differentiation as evi-
denced by loss of pluripotence and formation of differentiated cell
populations (Lake et al., 2000). However, unlike ES cell EBs, in
which cell populations representative of all three primary germ
layers and the extraembryonic endoderm can be detected, the
repertoire of cells produced from EPL cells EBs is more restricted
(Fig. 3). Brachyury, a marker of nascent mesoderm is detected
earlier and at a much higher level in EPL cell EBs compared to ES
cell EBs, but Sox1, a marker for the neural precursor population, is
not detected at any stage of differentiation. These differences in the
formation of progenitor cell populations are reflected in the forma-
tion of terminally differentiated cell populations, with the formation
within EPL cell EBs of high levels of beating cardiocytes, a
mesodermal derivative, but not neurons, an ectodermal derivative.
The lack of ectoderm formation within EPL cell EBs does not
reflect a restricted differentiation potential as neurectoderm/neu-
ron formation from EPL cells can be induced by differentiation
within an ES cell EB environment, the potent neural inducer retinoic
acid or supplementation of the differentiation environment with
MEDII (Lake et al., 2000; Rathjen et al., 2001). The most notable
difference between ES cell EBs and those formed from EPL cells
is in the extraembryonic endoderm lineage, in particular a defi-
ciency of the primitive endoderm derivative visceral endoderm in
EPL cell EBs (Lake et al., 2000). It has been suggested that this
deficiency may be responsible for the lack of ectodermal lineage
formation in EPL cell EBs (Rathjen et al., 2001; Rathjen et al, 2002).
In vivo, mesoderm differentiates from primitive ectoderm posi-
tioned along the posteriodistal axis. These cells detach from the
epithelial monolayer and transverse the primitive streak, an area of
localised ECM breakdown. EPL cell EBs, formed from a single cell
suspension of EPL cells differentiated in the absence of visceral



















* surface ectoderm induced from EBM by addition of BMP4 (J.Rathjen and C.Long, personal communication.)
not determined
not observed
ES cell EB EPL cell EB EBM
Fig. 3. Lineages formed during differentiation in ES cell EB, EPL cell EB
and EBM. Cell populations were determined on the basis of the following:
low and high levels of Fgf5 expression (early and late primitive ectoderm);
expression of alpha-feto protein and SPARC (visceral and parietal endo-
derm); expression of brachyury, Nkx 2.5 and Flk1, and phagocytosis of
opsonised beads (mesoderm progenitors, beating cardiocytes and mac-
rophages); expression of Sox1, Tubulin ß III isoform, Glial Fibrilliary Acidic
Protein, Sox10 and keratin 18 (neurectoderm, neurons, glia, neural crest
and surface ectoderm); expression of SPARC and morphology (endoderm).
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cell:ECM contacts which accompanies mesoderm formation. The
possibility that this simulated epithelial to mesenchymal transition
(EMT) underlies enhanced mesoderm formation is consistent with
studies of the behaviour of cells ablated in the Fgfr1 receptor during
gastrulation. Fgfr1-/- cells are unable to enter the primitive streak
during gastrulation and fail to contribute to the mesodermal lin-
eage, suggesting that primitive ectoderm EMT is required for
formation of mesoderm (Ciruna and Rossant, 2001; Ciruna et al.,
1997). Differentiation within EPL cell EBs therefore appears to
provide a model for the investigation of mesoderm lineage forma-
tion during gastrulation.
Within the embryo, the ectodermal lineage differentiates from
anteriodistal primitive ectoderm, a population of pluripotent cells
that maintains cell:cell and cell:ECM interactions and remains in
close contact with the visceral endoderm during gastrulation.
Maintenance of cell:cell and cell:ECM contacts and visceral endo-
derm signalling during EPL cell differentiation can be achieved by
formation and differentiation of EPL cells within cellular aggregates
in suspension culture in the presence of MEDII (EBMs). Differen-
tiation of EPL cells in this environment results in suppression of
both visceral endoderm and mesoderm lineage formation, and
formation of a homogeneous population of neurectoderm (Fig. 3;
Rathjen et al, 2002). The resulting neurectoderm population com-
prises a stratified epithelium with morphology, gene expression
trolled fashion provides an opportunity to dissect the roles of
individual signalling pathways during differentiation, and to dis-
criminate between the activity of soluble signalling molecules,
ECM and the cellular environment in both the induction and
suppression of alternate cell fates.
Pluripotent Cell Differentiation and Specification/Pat-
terning of Somatic Lineages
Allocation of ectodermal cells to the surface ectoderm or
neurectoderm lineages appears to be determined by respective
activation or suppression of BMP signalling pathways (Hemmati-
Brivanlou and Melton, 1997). In lower vertebrates this appears to
be mediated via antagonists of the BMP family of signalling
molecules, emanating from Spemann’s organiser. Although an
analogous structure is formed during embryogenesis in birds
(Henson’s node) and mammals (node), increasing evidence sug-
gests that these organiser structures and BMP antagonists in
higher vertebrates do not play an equivalent role in neural induction
(Blum et al., 1992; Cho et al., 1991; Rivera-Perez et al., 1995;
Yamada et al., 1995; Streit et al., 2000; Streit et al., 1998;
Klingensmith et al., 1999). While direct analysis of ectodermal
specification in the mammalian embryo has not yet been achieved,




























Fig. 4. Proposed mechanism of cavitation in ES cell embryoid bodies. After aggregation of ES
cells, outer cells differentiate to primitive endoderm followed by visceral endoderm, events that
require FGF and BMP signalling respectively. While visceral endoderm is shown here as homoge-
neous, parietal endoderm has also been demonstrated to form during this stage of EB differentiation.
With establishment of the extraembryonic endoderm lineage, a basement membrane is deposited
between the pluripotent cells and the endoderm. Basement membrane is proposed to induce an
alteration in the pluripotent cell state such that pluripotent cells in contact with the basement
membrane survive and reorganise to a columnar epithelium of primitive ectoderm, whereas those cells
centrally located and separate from the ECM undergo cell death, forming a cavity. It is unclear if the
acquisition of gene expression characteristic of primitive ectoderm within the pluripotent cells occurs
in response to signalling from the ECM or requires additional signals from the visceral endoderm.
and differentiation potential consistent with
embryonic neural tube. Expression analysis
of the marker genes Oct4, Rex1, Sox1 and
Gbx2 during formation of neurectoderm in
these aggregates suggests that differentia-
tion recapitulates formation of this lineage in
the embryo, with the sequential elaboration of
primitive ectoderm, definitive ectoderm, neu-
ral plate and neural tube (Rathjen et al, 2002).
The correspondence between ectoderm/
neurectoderm induction in vivo and in vitro,
both in morphology and sequential elabora-
tion of developmental intermediates, suggests
that directed differentiation of EPL cells pro-
vides a model system for analysis of the
establishment of the ectodermal and
neurectodermal lineages.
The formation of EPL cells from ES cells
provides a homogeneous population of primi-
tive ectoderm-like cells in culture, represent-
ing the immediate precursor cell of the three
primary germ layers. The ability to direct dif-
ferentiation of these cells to homogeneous
populations of differentiated derivatives relies
on the absence of alternate cell populations,
such as visceral endoderm, which act as a
source of endogenous differentiation induc-
ing signals (Lake et al., 2000; Rathjen et al.,
2001; Rathjen et al, 2002). The fact that differ-
entiation of EPL cells appears to recapitulate
establishment of the germ layers during de-
velopment validates this system for the analy-
sis of embryonic decisions following loss of
pluripotence. Experimentally, the ability to
modify the differentiation environment in con-
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differentiation of ES (Kawasaki et al., 2000) or EPL (C. Long,
personal communication; Rathjen et al., 2002) cells has been
shown to promote surface ectoderm formation at the expense of
neurogenesis. This suggests that while the cellular basis of ecto-
dermal specification in the mammalian embryo may differ from
equivalent events in lower vertebrates, the molecular regulation of
neural induction may be conserved.
During embryogenesis the neural tube acquires a complex
pattern of gene expression along the anterior/posterior and dorsal/
ventral axes in response to positional information emanating from
neighbouring cell populations such as the notochord and visceral
endoderm, and signalling centres such as the node and anterior
visceral endoderm (AVE) (Echelard et al., 1993; Liem et al., 1997;
Thomas and Beddington, 1996). Expression of diverse positionally
restricted genes can be detected within ES cell EBs, despite the
lack of positional organisation or establishment of anterior/poste-
rior and dorsal/ventral axes, presumably as a result of signalling
from the visceral endoderm and potentially from exposure of cells
to inappropriate cell populations and signalling molecules gener-
ated as a consequence of the chaotic environment. (Rathjen and
Rathjen, 2001). In contrast, formation of neurectoderm from EPL
cells results in a population of cells which do not express markers
characteristic of fore- or hind-brain, trunk neural tube, or dorsal/
ventral patterning, but do express markers characteristic of early
midbrain (Rathjen et al., 2002). The general lack of positional
specification within EBM, which is perhaps not unexpected given
the lack of visceral endoderm within these aggregates, suggests
that rather than midbrain, EBM comprise a population of naive, or
unpatterned, neurectoderm characterised by the expression of
pan-specific neural markers and the broadly expressed early
midbrain markers. The formation of neurectoderm by EBM differ-
entiation therefore separates neural induction from the manifesta-
tion of positional specification, processes which during embryo-
genesis occur concomitantly and have not been uncoupled experi-
mentally.
Pluripotent Cell Differentiation can be used as a Model
of Morphogenesis
Establishment of the primitive ectoderm in both the embryo and
EBs occurs concurrently with the formation of a cavity, termed the
proamniotic cavity during embryogenesis, in the pluripotent cell
mass. The mechanism of cavity formation has been studied in vitro
using the differentiation of pluripotent cells as EBs, a system more
tractable to analysis than the embryo. Although cavitation in vivo
occurs when the epiblast comprises less than 120 cells (Snow,
1977), many less than are present in an EB at cavitation, the
mechanism of cavity formation is suggested to be conserved
between these systems (Coucouvanis and Martin, 1995). Cavity
formation in EBs is initiated with the formation of multiple foci of cell
death which merge to a single, centrally located cavity surrounded
by a monolayer of primitive ectoderm cells. EB cavitation has been
suggested to result from integrated action of a diffusible ‘death’
signal secreted by the visceral endoderm and a survival signal
associated with the ECM separating the endoderm and primitive
ectoderm cell populations (Coucouvanis and Martin, 1995). Con-
sistent with this, disruption of FGF signalling in EBs, by expression
of a dominant negative FGF receptor, resulted in both loss of the
extraembryonic endodermal lineage and disruption of cavitation
(Chen et al., 2000). Further, the expression of Bmp2 and Bmp4 by
pluripotent cells at the time of visceral endoderm formation and
cavity formation was shown to be required for both processes, as
disruption of BMP signalling inhibited expression of visceral endo-
derm markers and prevented cavity formation (Coucouvanis and
Martin, 1999).
Although the above experimental approaches demonstrate a
requirement for extraembryonic endodermal lineages in EB cavi-
tation, the role of a death signal in this process has been ques-
tioned. EBs formed from LAMC1-/- ES cells, which fail to establish
a basement membrane, are deficient in cavitation despite the
formation of extraembryonic endoderm. Cavitation can be restored
in these aggregates by addition of ECM components to the
differentiation environment (Murray and Edgar, 2000). The failure
of cavitation, but not the deficiency in extraembryonic endoderm,
in EB formed from ES cells expressing the dominant negative FGF
receptor can also be restored by supplementation of the differen-
tiation environment with ECM (Li et al., 2001). Cavitation and
formation of primitive ectoderm is observed during the differentia-
tion of ES cells as EBM, despite these aggregates being deficient
in the extraembryonic lineage (Rathjen et al., 2002). Within EBM,
cavitation proceeds via the formation of a single, centrally located
cavity rather than the formation of multiple, discrete foci of death as
seen in EB. MEDII is proposed to provide a source of visceral





Fig. 5. Molecular analysis of genes differentially expressed by pluripotent cells. (A) Whole mount in situ hybridisation of a 4.5 d.p.c. mouse blastocyst
(left) and sectioned 16.5 d.p.c. embryonic kidney (right) using a digoxygenin labelled CRTR-1 specific anti-sense riboprobe. Scale bars represent 10 µm
and 100 µm respectively. ICM, inner cell mass; D, distal convoluted tubule; P, proximal convoluted tubule; G, glomerulous. (B) Confocal microscopy of
a COS-1 cell transiently transfected with EGFP-Psc1. Scale bar indicates 10 µm. The nucleus of the cell is stained with propidium iodide (red). Nuclear
speckles and cyto-speckles are visible within the nucleus and cytoplasm respectively.
 ES Cell Differentiation and Mammalian Development        455
ECM components, such as cellular fibronectin (Bettess, 2001),
suggesting that the role of visceral endoderm in cavitation is
deposition of a basement membrane.
The ability of ECM components to reconstitute cavitation in
pluripotent cells in the absence of extraembryonic endoderm
suggests that both pluripotent death and survival are induced by
the basement membrane (Fig. 4). The role of ECM deposition may
be to alter the pluripotent state such that direct association with
ECM components within the basement membrane is required for
cell survival. It is unclear if differentiation of the surviving cells to
primitive ectoderm is also induced by the basement membrane as
establishment of the identity of the pluripotent cells at the time of the
formation of a columnar epithelial of cells has only been estab-
lished in EB and EBM, in which additional visceral endoderm-like
signalling may be present.
Functional Analysis of Genes Differentially Expressed
during Pluripotent Cell Differentiation
ES cells provide a valid model system for investigation of the
properties associated with pluripotent cells. In vitro manipulation of
ES cells has been used to investigate the molecular basis of
pluripotence (Niwa et al., 2000), unusual regulation of cell cycle
progression (Savatier et al., 1996), telomere maintenance
(Armstrong et al., 2000), the cellular basis of nuclear reprogram-
ming (Tada et al., 2001) and signalling pathways associated with
loss of pluripotence (Burdon et al., 1999). The close relationship
between EPL cells and embryonic primitive ectoderm suggests
that ES cell differentiation can also be used to analyse the de-
velopmental progression of embryonic cells, with the function of
differentially expressed pluripotent cell specific genes providing
novel insight into the molecular and cellular basis of alterations in
cell biology during differentiation.
CRTR-1 is a Developmentally Regulated Transcriptional
Repressor
The CRTR-1 cDNA encodes a 481 amino acid open reading
frame homologous with the CP2 family of transcription factors
(Rodda et al., 2001). Conservation between CRTR-1 and other
mammalian family members is extensive and includes regions
implicated in DNA binding and protein oligomerisation but not
transcriptional activation.
Members of the CP2 family are generally expressed ubiqui-
tously (Jane et al., 1995). By contrast, CRTR-1 is expressed
specifically in the pluripotent cells of the 3.5-4.75 d.p.c. mouse
embryo and at high levels in the epithelial monolayer lining the
embryonic and adult kidney distal convoluted tubules (Fig. 5A).
While both pluripotent cells and the DCT lining are epithelial in
origin, CRTR-1 expression is not a general property of such cells
as other epithelial cells including the lining of kidney proximal
convoluted tubules do not express detectable CRTR-1. Both sites
of CRTR-1 expression in vivo are associated with cavitation
(Horster et al., 1997) suggesting a role for the protein in precursor
cell survival or apoptosis (Coucouvanis and Martin, 1995). Addi-
tional sites of lower level expression have been identified by
ribonuclease protection and include embryonic intestine, limb,
lung, skin and adult placenta, testis, stomach and small intestine.
These have not been resolved at the cellular level.
Members of the CP2 family bind a consensus DNA sequence
consisting of a direct bipartite repeat, CNRG-N6-CNRG, and acti-
vate transcription (Lim et al., 1993). CRTR-1 is the first member of
the family shown to repress transcription when bound to a heterolo-
gous promoter in a variety of cell lines including kidney (293T and
COS-1 cells) and ES cells. The transcriptional repression activity
was found to be localised to the N-terminal 52 amino acids which
are both necessary and sufficient for CRTR-1-mediated transcrip-
tional repression (Rodda et al., 2001).
CRTR-1 has also been demonstrated to interact with other
family members including CP2 and LBP-1a by yeast two hybrid and
GST-pull down analysis (S. Rodda and P. Rathjen, unpublished
data). Inter-family interactions between CP2 family members such
as CP2 and LBP-1a (Yoon et al., 1994) suggest the formation of
multiprotein complexes which regulate gene expression. The
properties of CRTR-1 are therefore consistent with a role as a
developmentally regulated, dominant repressor of target genes
activated by CP2 family members, associated with embryological
events such as differentiation and cavitation.
Psc1 is a Developmentally Regulated SR Protein with a
Novel Role in RNA Metabolism
The 1,005 amino acid open reading frame of Psc1 contains an
RNA binding domain and an arginine, serine rich region of 25
amino acids including four RS dipeptide repeats, identifying it as a
member of the SR-like family of proteins. Psc1 is expressed
temporally throughout the pluripotent cell pool within the early
embryo and at elevated levels in embryonic brain and adult lung
and placenta (Schulz, 1996).
SR proteins contribute to spliceosome formation and have been
implicated in both constitutive splicing and alternate splice site
selection (for review see Caceres et al., 1998). Consistent with this,
SR proteins localise to 20 to 50 discrete regions within the nucleus
termed nuclear speckles, which contain snRNPs, non snRNP’s
and other splicing factors (Mintz and Spector, 2000). The SR
protein SC35 (Fu and Maniatis, 1990) colocalises with GFP-Psc1
to nuclear speckles in transiently transfected Cos-1 cells. In
addition, GFP-Psc1 localises to a large number of discrete, punc-
tate regions throughout the cytoplasm, termed cytospeckles, which
do not contain SC35 (Fig. 5B). Although nuclear-cytoplasmic
shuttling has been reported for SR proteins such as SF2/ASF,
SRp20 and 9G8 (Caceres et al., 1998) and U2AF (Gama-Carvalho
et al., 2001), these proteins do not show punctate cytoplasmic
localisation of the kind associated with cytospeckles. Psc1 there-
fore differs from other SR proteins with respect to its developmental
regulation and regionalised cytoplasmic distribution.
Psc1 containing cytospeckles are reminiscent of RNA granules
which traffic via the cytoskeleton (Bassell et al., 1999), colocalise
with microtubules and contain translational machinery such as
ribosomal sub units and elongation factors (Hazelrigg, 1998).
Consistent with this, real time analysis of GFP-Psc1 transfected
cells shows that Psc1 containing cytospeckles are motile within the
cytoplasm. In contrast to RNA granules however, cytospeckles
undergo nuclear import although nuclear export has not been
observed (Kavanagh, 1998).
The presence of both RNA and protein interaction motifs in the
Psc1 sequence suggests that Psc1-containing speckles in the
nucleus and the cytoplasm are likely to be RNA-protein complexes.
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Developmental regulation of Psc1 expression suggests that
regionalised cytoplasmic localisation and/or nuclear transport of
specific RNA and/or protein cargo’s is likely to be of developmental
significance. While the cellular relevance of cytospeckles is un-
known, cytoplasmic localisation of RNA might allow transcripts to be
targeted for site specific localisation, degradation or translation,
which could be used to establish asymmetry within the cell. Similar
localisation of the D. melanogaster neuroblast transcript, prospero,
(Li et al., 1997) and the S. cerevisaie transcript ASH1 (Long et al.,
1997) provide a mechanism for differentiation in the developing
embryo.
PRCE functions as a Developmentally Regulated Mam-
malian Separin
The PRCE cDNA encodes a 2118 amino acid open reading frame
(Pelton, 2000) that shares C terminal homology with the separin
domain (Leismann et al., 2000) of three fungal separin proteins,
ESP1 from S. cerevisiae (Baum et al., 1988; McGrew et al., 1992),
cut1 from S. pombe (Uzawa et al., 1990), and bimB from A. nidulans
(May et al., 1992). These proteins are members of the CD group of
cysteine proteases, a class that also includes caspases (Uhlmann et
al., 2000), which mediate chromosome segregation at the onset of
anaphase through cleavage of the cohesin subunit complex.
Expression of PRCE is developmentally regulated. It is expressed
specifically in the pluripotent cells of the mouse embryo from 4.75 to
5.25 d.p.c. and later in mouse adult tissues including bone marrow,
testis and intestine (Pelton, 2000; Pelton et al., 2002). These tissues
contain stem cell and/or progenitor cell pools and are associated with
rapid cell proliferation. Biochemical properties of the PRCE protein
are consistent with the proposed function in cell division. In fungi,
separin activity is confined to anaphase in two ways: via sequestation
of the protein in the cytoplasm before mitosis and by the formation of
tight inhibitory complexes with securin proteins. Cohesin cleavage at
the onset of anaphase is achieved by activation of separin proteases
following APC mediated ubiquitination and degradation of the securins.
Consistent with this, GFP-PRCE sub-cellular localisation is cytoplas-
mic within the majority of transfected cells, but also observed at the
centrosome, the site of microtubule nucleation required for mitotic
spindle formation. Furthermore, PRCE interacts with and colocalises
the mouse securin PTTG, and over expression of PRCE inhibits cell
cycle progression in somatic cells (T. Pelton and P. Rathjen, unpub-
lished data). PRCE therefore appears to be a novel developmentally
regulated mammalian separin.
Manipulation of separin/securin function can lead to aneuploidy
(Jallepalli et al., 2001). In this regard, it is interesting that PRCE is
expressed in pluripotent cells which exhibit unusual genomic stability
in vitro (Pera et al., 2000). Further, regulated expression of a separin
protease in rapidly dividing cells suggests that progression through
an anaphase checkpoint in the cell cycle can be used to accelerate
cell division in a developmental context. Differential expression of cell
cycle regulators may therefore provide opportunities to alter the
properties of embryonic cell populations such as pluripotent cells
which have an unusual cell cycle structure (Savatier et al., 1996).
Summary
Understanding the events of early mammalian embryogenesis
at the molecular and cellular level is hampered by difficulties
associated with experimental inaccessibility of the embryo. Fur-
thermore, unlike many developmental processes which can be
investigated using analogy with the development of more tractable
experimental models, early mammalian embryogenesis involves
the elaboration and differentiation of a unique population of pluri-
potent cells which are not present in embryos of lower vertebrates.
In vitro, model systems for early development exploiting pluripotent
cells in culture have been available for more than 15 years, but until
recently difficulties in controlling the differentiation of these cells
has limited their application to the questions of mammalian devel-
opment. Utilising conditioned medium that appears to recapitulate
the signalling activities of extraembryonic endoderm in culture, we
have demonstrated the homogeneous differentiation of ES cells to
a second, pluripotent cell population, EPL cells, which show
equivalence to embryonic primitive ectoderm. EPL cell formation in
vitro provides a model system for characterisation of pluripotent
cells, which has led to the identification of discrete transient cell
states formed during establishment of primitive ectoderm in vivo.
Further, the availability of a homogeneous population of primitive
ectoderm, the immediate precursor population of the three primary
germ layers, has allowed the development of model systems for
directed differentiation and cell fate specification during gastrulation.
Analysis of EPL cell differentiation has facilitated the uncoupling of
events that occur concomitantly during embryogenesis, such as
induction and patterning of the neural lineage, and dissection of the
signalling environments that control pluripotent cell differentiation,
allowing the relative roles of soluble signalling molecules, ECM
associated activities and cellular environment to be assessed. The
ability to generate essentially homogeneous populations of cells
representing differentiation intermediates provides a unique oppor-
tunity to study both the developmental potential and gene expression
profile of cells that exist only transiently in the embryo.
Acknowledgments
We would like to thank Dr. Tricia Pelton, Dr. Michael Bettess, Catheine
Long and Philippa Davey for helpful discussions regarding pluripotent cell
gene expression, factors contained within MEDII, ectodermal differentia-
tion and Psc1 localisation. The intellectual and technical contributions
made by past and present members of the Rathjen laboratory is also
gratefully acknowledged. We would also like to acknowledge the support
of Raymond Ryce for research into embryonic stem cells in our laboratory.
Research was supported by the Australian Research Council and the
National Health and Medical Research Council.
References
ARMSTRONG, L., LAKO, M., LINCOLN, J., CAIRNS, P. M., and HOLE, N. (2000).
mTert expression correlates with telomerase activity during the differentiation of
murine embryonic stem cells. Mech Dev 97: 109-16.
BASSELL, G. J., OLEYNIKOV, Y., and SINGER, R. H. (1999). The travels of mRNAs
through all cells large and small. Faseb J 13: 447-54.
BAUM, P., YIP, C., GOETSCH, L., and BYERS, B. (1988). A yeast gene essential for
regulation of spindle pole duplication. Mol. Cell. Biol. 8: 5386-5397.
BEDDINGTON, R. S. P. (1983a). The origin of foetal tissues during gastrulation in the
rodent, Volume 5, M. H. Johnson, ed. (Amsterdam: Elsevier).
BEDDINGTON, R. S. (1983b). Histogenetic and neoplastic potential of different
regions of the mouse embryonic egg cylinder. J Embryol Exp Morphol 75: 189-204.
BEDDINGTON, R. S., and ROBERTSON, E. J. (1999). Axis development and early
asymmetry in mammals. Cell 96: 195-209.
BEN-SHUSHAN, E., THOMPSON, J. R., GUDAS, L. J., and BERGMAN, Y. (1998).
Rex1, a gene encoding a transcription factor expressed in the early embryo, is
regulated via Oct-3/4 and Ocy-6 binding to an Octomer site and a novel protein,
Rox-1, binding to an adjacent site. Mol. Cell. Biol. 18: 1866-1878.
 ES Cell Differentiation and Mammalian Development        457
BETTESS, M. D. (2001). Purification, Identification and Characterisation of Signals
Directing Embryonic Stem (ES) cell differentiation. In Department of Molecular
Biosciences (Adelaide, South Australia: Adelaide University).
BLUM, M., GAUNT, S. J., CHO, K. W., STEINBEISSER, H., BLUMBERG, B.,
BITTNER, D., and DE ROBERTIS, E. M. (1992). Gastrulation in the mouse: the
role of the homeobox gene goosecoid. Cell 69: 1097-106.
BRADLEY, I., EVANS, M., KAUFMAN, M. H., and ROBERTSON, E. J. (1984).
Formation of germ line chimeras from embryo-derived teratocarcinoma cell lines.
Nature 309: 255-256.
BURDON, T., STRACEY, C., CHAMBERS, I., NICHOLS, J., and SMITH, A. (1999).
Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse
embryonic stem cells. Dev Biol 210: 30-43.
CACERES, J. F., SCREATON, G. R., and KRAINER, A. R. (1998). A specific subset
of SR proteins shuttles continuously between the nucleus and the cytoplasm.
Genes Dev 12: 55-66.
CHAPMAN, G., REMISZEWSKI, J. L., WEBB, G. C., SCHULZ, T. C., BOTTEMA, C.
D., and RATHJEN, P. D. (1997). The mouse homeobox gene, Gbx2: genomic
organization and expression in pluripotent cells in vitro and in vivo. Genomics 46:
223-33.
CHEN, Y., LI, X., ESWARAKUMAR, V. P., SEGER, R., and LONAI, P. (2000).
Fibroblast growth factor (FGF) signaling through PI 3-kinase and Akt/PKB is
required for embryoid body differentiation. Oncogene 19: 3750-6.
CHO, K. W., BLUMBERG, B., STEINBEISSER, H., and DE ROBERTIS, E. M. (1991).
Molecular nature of Spemann’s organizer: the role of the Xenopus homeobox
gene goosecoid. Cell 67: 1111-20.
CIRUNA, B., and ROSSANT, J. (2001). FGF signaling regulates mesoderm cell fate
specification and morphogenetic movement at the primitive streak. Dev Cell 1:
37-49.
CIRUNA, B. G., SCHWARTZ, L., HARPAL, K., YAMAGUCHI, T. P., and ROSSANT,
J. (1997). Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function:
a role for FGFR1 in morphogenetic movement through the primitive streak.
Development 124: 2829-41.
CONQUET, F., PEYRIERAS, N., TIRET, L., and BRULET, P. (1992). Inhibited
gastrulation in mouse embryos overexpressing the leukemia inhibitory factor.
Proc Natl Acad Sci U S A 89: 8195-9.
COUCOUVANIS, E., and MARTIN, G. R. (1999). BMP signaling plays a role in visceral
endoderm differentiation and cavitation in the early mouse embryo. Development
126: 535-46.
COUCOUVANIS, E., and MARTIN, G. R. (1995). Signals for death and survival: a two-
step mechanism for cavitation in the vertebrate embryo. Cell 83: 279-87.
DOETSCHMAN, T. C., EISTETTER, H., KATZ, M., SCHMIDT, W., and KEMLER, R.
(1985). The in vitro development of blastocyst-derived embryonic stem cell lines:
formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp
Morphol 87: 27-45.
DUNCAN, S. A., MANOVA, K., CHEN, W., HOODLESS, P., WIENSTEIN, D. C.,
BACHAROVA, R. F., and DARNELL JR, J. E. (1994). Expression of transcription
factor HNF-4 in the extraembryonic endoderm, gut and nephrogenic tissue of the
developing mouse embryo: HNF-4 is a marker for primary endoderm in the
implantating blastocyst. Proc. Natl. Acad. Sci. USA 91: 7598-7602.
DUNCAN, S. A., NAGY, A., and CHAN, W. (1997). Murine gastrulation requires HNF-
4 regulated gene expression in the visceral endoderm: tetraploid rescue of HNF-
4-/- embryos. Development 124: 279-287.
ECHELARD, Y., EPSTEIN, D. J., ST-JACQUES, B., SHEN, L., MOHLER, J.,
MCMAHON, J. A., and MCMAHON, A. P. (1993). Sonic hedgehog, a member of
a family of putative signaling molecules, is implicated in the regulation of CNS
polarity. Cell 75: 1417-30.
EVANS, M. J., and KAUFMAN, M. H. (1981). Establishment in culture of pluripotential
cells from mouse embryos. Nature 292: 154-6.
FU, X. D., and MANIATIS, T. (1990). Factor required for mammalian spliceosome
assembly is localized to discrete regions in the nucleus. Nature 343: 437-41.
GAMA-CARVALHO, M., CARVALHO, M. P., KEHLENBACH, A., VALCARCEL, J.,
and CARMO-FONSECA, M. (2001). Nucleocytoplasmic shuttling of heterodimeric
splicing factor U2AF. J Biol Chem 276: 13104-12.
HAZELRIGG, T.B (1998). The destinies and destinations of RNAs. Cell 95: 451-60.
HEMMATI-BRIVANLOU, A., and MELTON, D. (1997). Vertebrate embryonic cells will
become nerve cells unless told otherwise. Cell 88: 13-7.
HOGAN, B., BEDDINGTON, R., CONSTANTINI, F., and LACY, E. (1994). Manipu-
lating the Mouse Embryo: A Laboratory Manual, (2nd. Edn.) Edition (Cold Spring
Harbour, NY: Cold Spring Harbour Laboratory Press).
HORSTER, M., HUBER, S., TSCHOP, J., DITTRICH, G., and BRAUN, G. (1997).
Epithelial nephrogenesis. Pflugers Arch 434: 647-60.
JALLEPALLI, P. V., WAIZENEGGER, I. C., BUNZ, F., LANGER, S., SPEICHER, M. R.,
PETERS, J. M., KINZLER, K. W., VOGELSTEIN, B., and LENGAUER, C. (2001).
Securin is required for chromosomal stability in human cells. Cell 105: 445-57.
JANE, S. M., NIENHUIS, A. W., and CUNNINGHAM, J. M. (1995). Hemoglobin
switching in man and chicken is mediated by a heteromeric complex between the
ubiquitous transcription factor CP2 and a developmentally specific protein [pub-
lished erratum appears in EMBO J 14: 854]. EMBO J 14: 97-105.
KAVANAGH, S.J. (1998). The pluripotent stem cell marker Psc1 localises to nuclear
speckles. In Department of Biochemistry (Adelaide, South Australia: Adelaide
University)
KAWASAKI, H., MIZUSEKI, K., NISHIKAWA, S., KANEKO, S., KUWANA, Y.,
NAKANISHI, S., NISHIKAWA, S. I., and SASAI, Y. (2000). Induction of midbrain
dopaminergic neurons from ES cells by stromal cell-derived inducing activity.
Neuron 28: 31-40.
KLINGENSMITH, J., ANG, S. L., BACHILLER, D., and ROSSANT, J. (1999). Neural
induction and patterning in the mouse in the absence of the node and its
derivatives. Dev Biol 216: 535-49.
LAKE, J., RATHJEN, J., REMISZEWSKI, J., and RATHJEN, P. D. (2000). Reversible
programming of pluripotent cell differentiation. J Cell Sci 113: 555-66.
LEISMANN, O., HERZIG, A., HEIDMANN, S., and LEHNER, C. F. (2000). Degrada-
tion of Drosophila PIM regulates sister chromatid separation during mitosis.
Genes Dev 14: 2192-205.
LI, P., YANG, X., WASSER, M., CAI, Y., and CHIA, W. (1997). Inscuteable and
Staufen mediate asymmetric localization and segregation of prospero RNA during
Drosophila neuroblast cell divisions. Cell 90: 437-47.
LI, X., CHEN, Y., SCHEELE, S., ARMAN, E., HAFFNER-KRAUSZ, R., EKBLOM, P.,
and LONAI, P. (2001). Fibroblast growth factor signaling and basement mem-
brane assembly are connected during epithelial morphogenesis of the embryoid
body. J Cell Biol 153: 811-22.
LIEM, K. F., JR., TREMML, G., and JESSELL, T. M. (1997). A role for the roof plate
and its resident TGFbeta-related proteins in neuronal patterning in the dorsal
spinal cord. Cell 91: 127-38.
LIM, L. C., FANG, L., SWENDEMAN, S. L., and SHEFFERY, M. (1993). Character-
ization of the molecularly cloned murine alpha-globin transcription factor CP2. J
Biol Chem 268: 18008-17.
LONG, R. M., SINGER, R. H., MENG, X., GONZALEZ, I., NASMYTH, K., and
JANSEN, R. P. (1997). Mating type switching in yeast controlled by asymmetric
localization of ASH1 mRNA. Science 277: 383-7.
MARTIN, G. R. (1981). Isolation of a pluripotent cell line from early mouse embryos
cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci
USA 78: 7634-8.
MARTINEZ-BARBERA, J. P., RODRIGUEZ, T. A., and BEDDINGTON, R. S. (2000).
The homeobox gene Hesx1 is required in the anterior neural ectoderm for normal
forebrain formation. Dev Biol 223: 422-30.
MATSUI, Y., ZSEBO, K., and HOGAN, B. L. (1992). Derivation of pluripotential
embryonic stem cells from murine primordial germ cells in culture. Cell 70: 841-7.
MAY, G. S., MCGOLDRICK, C. A., HOLT, C. L., and DENISON, S. H. (1992). The
bimB3 mutation of aspergillus nidulans uncouples DNA replication from the
completion of mitosis. J. Biol. Chem. 267: 15737-15743.
MCGREW, J. T., GOETSCH, L., BYERS, B., and BAUM, P. (1992). Requirement for ESP1
in the nuclear division of Saccharomyces cerevisiae. Mol. Biol. Cell 3: 1443-1454.
MINTZ, P. J., and SPECTOR, D. L.B (2000). Compartmentalization of RNA process-
ing factors within nuclear speckles. J Struct Biol 129: 241-51.
MURRAY, P., and EDGAR, D. (2000). Regulation of programmed cell death by
basement membranes in embryonic development. J Cell Biol 150: 1215-21.
NICHOLS, J., CHAMBERS, I., TAGA, T., and SMITH, A. (2001). Physiological
rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines.
Development 128: 2333-9.
NIWA, H., MIYAZAKI, J., and SMITH, A. G. (2000). Quantitative expression of Oct-3/
4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Gen. 24:
372-376.
458          S.J. Rodda et al.
PARAMESWARAN, M., and TAM, P. P. L. (1995). Regionalisation of cell fate and
morphogenetic movement of the mesoderm during mouse gastrulation. Dev.
Genet. 17: 16-28.
PELTON, T. A., SHARMA, S., SCHULZ, T.C., RATHJEN, J. and RATHJEN, P.D.
(2002). Transient pluripotent cell populations during primitive ectoderm formation:
Correlation of in vivo and in vitro pluripotent cell development. J Cell Sci. 115: 329-339.
PELTON, T. (2000). Expression and function of genes identifying pluripotent cell sub-
populations in the early mouse embryo. In Department of Biochemistry (Adelaide,
South Australia: Adelaide University)
PELTON, T. A., BETTESS, M. D., LAKE, J., RATHJEN, J., and RATHJEN, P. D.
(1998). Developmental complexity of early mammalian pluripotent cell popula-
tions in vivo and in vitro. Reprod Fertil Dev 10: 535-49.
PERA, M.P., REUBINOFF, B. and TROUNSON, A. (2000). Human embryonic stem
cells. J Cell Sci 113: 5-10.
RATHJEN, J., LAKE, J. A., BETTESS, M. D., WASHINGTON, J. M., CHAPMAN, G.,
and RATHJEN, P. D. (1999). Formation of a primitive ectoderm like cell population,
EPL cells, from ES cells in response to biologically derived factors. J Cell Sci 112:
601-12.
RATHJEN, J., and RATHJEN, P. D. (2001). Mouse ES cells: experimental exploitation
of pluripotent differentiation potential. Curr Opin Genet Dev 11: 587-94.
RATHJEN, J., DUNN, S., BETTESS, M. D., and RATHJEN, P. D. (2001). Lineage
specific differentiation of pluripotent cells in vitro: a role for extraembryonic cell
types. Reprod Fertil Dev 13: 15-22.
RATHJEN, J., HAINES, B.P., HUDSON, K.M., NESCI, A., DUNN, S., and RATHJEN,
P.D. (2002). Directed differentiation of pluripotent cells to neural lineages: homo-
geneous formation and differentiation of a neurectoderm population. Develop-
ment (in press).
RIVERA-PEREZ, J. A., MALLO, M., GENDRON-MAGUIRE, M., GRIDLEY, T., and
BEHRINGER, R. R. (1995). Goosecoid is not an essential component of the
mouse gastrula organizer but is required for craniofacial and rib development.
Development 121: 3005-12.
RODDA, S., SHARMA, S., SCHERER, M., CHAPMAN, G., and RATHJEN, P.D.
(2001). CRTR-1, a developmentally regulated transcriptional repressor related to
the CP2 family of transcription factors. J Biol Chem 276: 3324-32.
ROSSANT, J. (1993). Immortal Germ Cells? Current Biology 3: 47-49.
ROSSANT, J. (1995). Development of the extraembryonic lineages. Semin. Cell Dev.
Biol. 6: 237-47.
SAVATIER, P., LAPILLONNE, H., VAN GRUNSVEN, L. A., RUDKIN, B. B., and
SAMARUT, J. (1996). Withdrawal of differentiation inhibitory activity/leukemia
inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibi-
tors in mouse embryonic stem cells. Oncogene 12: 309-22.
SCHULZ, T. C. (1996). A system for the isolation of markers for subpopulations of
murine pluripotent cells. In Department of Biochemistry (Adelaide, South Austra-
lia: Adelaide University).
SHEN, M. M., and LEDER, P. (1992). Leukemia inhibitory factor is expressed by the
preimplantation uterus and selectively blocks primitive ectoderm formation in
vitro. Proc Natl Acad Sci USA 89: 8240-4.
SNOW, M. H. L. (1977). Gastrulation in the mouse: Growth and regionalisation of
the epiblast. J. Embryol. exp. Morph. 42: 293-303.
SPYROPOULOS, D. D., and CAPPECHI, M. R. (1994). Targeted disruption of the
even-skipped gene, evx1, causes early post-implantation lethality of the mouse
conceptus. Genes & Dev. 8: 1949-1961.
STREIT, A., BERLINER, A. J., PAPANAYOTOU, C., SIRULNIK, A., and STERN, C.
D. (2000). Initiation of neural induction by FGF signalling before gastrulation.
Nature 406: 74-8.
STREIT, A., LEE, K. J., WOO, I., ROBERTS, C., JESSELL, T. M., and STERN, C.
D. (1998). Chordin regulates primitive streak development and the stability of
induced neural cells, but is not sufficient for neural induction in the chick embryo.
Development 125: 507-19.
TADA, M., TAKAHAMA, Y., ABE, K. NAKATSUJI, N., and TADA, T. (2001). Nuclear
reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol.
11:1553-8.
TAM, P. P. L., and ZHOU, S. X. (1996). The allocation of epiblast cells to ectodermal
and germ-line lineages is influnced by the position of the cells in the gastrulating
mouse embryo. Dev. Biol. 178: 124-132.
THOMAS, P. Q., and BEDDINGTON, R. S. P. (1996). Anterior primitive endoderm
may be responsible for patterning the anterior neural plate in the mouse embryo.
Curr. Biol. 6: 1487-1496.
UHLMANN, F., WERNIC, D., POUPART, M. A., KOONIN, E. V., and NASMYTH, K.
(2000). Cleavage of cohesin by the CD clan protease separin triggers anaphase
in yeast. Cell 103: 375-86.
UZAWA, S., SAMEJIMA, I., HIRANO, T., TANAKA, K., and YANAGIDA, M. (1990).
The fission yeast cut1+ gene regulates spindle pole body duplication and has
homolgy to the budding yeast ESP1 gene. Cell 62: 913-925.
YAMADA, G., MANSOURI, A., TORRES, M., STUART, E. T., BLUM, M., SCHULTZ,
M., DE ROBERTIS, E. M., and GRUSS, P. (1995). Targeted mutation of the
murine goosecoid gene results in craniofacial defects and neonatal death.
Development 121: 2917-22.
YOON, J. B., LI, G., and ROEDER, R. G. (1994). Characterization of a family of
related cellular transcription factors which can modulate human immunode-
ficiency virus type 1 transcription in vitro. Mol Cell Biol 14: 1776-85.
YOSHIDA, K., TAGA, T., SAITO, M., SUEMATSU, S., KUMANOGOH, A.,
TANAKA, T., FUJIWARA, H., HIRATA, M., YAMAGAMI, T., NAKAHATA, T.,
HIRABAYASHI, T., YONEDA, Y., TANAKA, K., WANG, W. Z., MORI, C.,
SHIOTA, K., YOSHIDA, N., and KISHIMOTO, T. (1996). Targeted disruption
of gp130, a common signal transducer for the interleukin 6 family of cytokines,
leads to myocardial and hematological disorders. Proc Natl Acad Sci USA 93:
407-11.
